These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26941397)

  • 1. Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations.
    Pan W; Zhou L; Ge M; Zhang B; Yang X; Xiong X; Fu G; Zhang J; Nie X; Li H; Tang X; Wei J; Shao M; Zheng J; Yuan Q; Tan W; Wu C; Yang M; Lin D
    Hum Mol Genet; 2016 May; 25(9):1875-84. PubMed ID: 26941397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA GAS8-AS1 genetic alterations in papillary thyroid carcinoma and their clinical significance.
    Zhou DL; Liu Q; Xu BH; Li Y; Su X; Ye ZL; Zhang X; Peng JL; Deng L; Tang T; Shao Q; Ma JJ; Yang XH; He CY
    Cancer Biomark; 2020; 29(2):255-264. PubMed ID: 32675393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA GAS8-AS1 dinucleotide genetic variant
    Murugan AK; Al-Hindi H; Alzahrani AS
    Endocrine; 2024 Sep; 85(3):1278-1288. PubMed ID: 38580894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer.
    Qin Y; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T; Shao L; Zhang W; Wu C
    Endocrine; 2018 Mar; 59(3):555-564. PubMed ID: 29327301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
    Chen N; Yin D; Lun B; Guo X
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.
    Wang Q; Yang H; Wu L; Yao J; Meng X; Jiang H; Xiao C; Wu F
    Thyroid; 2016 Dec; 26(12):1719-1732. PubMed ID: 27758138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing.
    Chang CC; Chang YS; Huang HY; Yeh KT; Liu TC; Chang JG
    Hum Pathol; 2018 Aug; 78():151-158. PubMed ID: 29753010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA CCND2-AS1 promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
    Xia E; Bhandari A; Shen Y; Zhou X; Sindan N; Xiang J; Guan Y; Yang F; Wang O
    Biochem Biophys Res Commun; 2018 Feb; 496(2):628-632. PubMed ID: 29366479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Profile of Genetic Mutations in Papillary Thyroid Cancer Detected by Whole Exome Sequencing.
    Fang Y; Ma X; Zeng J; Jin Y; Hu Y; Wang J; Liu R; Cao C
    Cell Physiol Biochem; 2018; 50(1):169-178. PubMed ID: 30278442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA GAS8-AS inhibits colorectal cancer (CRC) cell proliferation by downregulating lncRNA AFAP1-AS1.
    Zhao Y; Chu Y; Sun J; Song R; Li Y; Xu F
    Gene; 2019 Aug; 710():140-144. PubMed ID: 31132513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lncRNA GAS8-AS1 as a Potential Biomarker of Papillary Thyroid Carcinoma in Chinese Patients.
    Zhang D; Liu X; Wei B; Qiao G; Jiang T; Chen Z
    Int J Endocrinol; 2017; 2017():2645904. PubMed ID: 28781594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
    Costa AM; Herrero A; Fresno MF; Heymann J; Alvarez JA; Cameselle-Teijeiro J; García-Rostán G
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
    Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
    Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and function of long noncoding RNA lncRNA-ATB in papillary thyroid cancer.
    Fu XM; Guo W; Li N; Liu HZ; Liu J; Qiu SQ; Zhang Q; Wang LC; Li F; Li CL
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3239-3246. PubMed ID: 28770959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long noncoding RNA
    Pan W; Zhang N; Liu W; Liu J; Zhou L; Liu Y; Yang M
    J Biol Chem; 2018 Nov; 293(44):17154-17165. PubMed ID: 30228180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer.
    Ma B; Liao T; Wen D; Dong C; Zhou L; Yang S; Wang Y; Ji Q
    Sci Rep; 2016 Nov; 6():36973. PubMed ID: 27833134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
    Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
    Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma.
    Hou S; Zhuang YY; Lin QY; Chen Z; Zhao HG; Zhang L; Lin CH
    Exp Mol Pathol; 2021 Aug; 121():104658. PubMed ID: 34102210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
    Zhao Y; Wang H; Wu C; Yan M; Wu H; Wang J; Yang X; Shao Q
    Oncol Rep; 2018 Mar; 39(3):1197-1206. PubMed ID: 29328463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.